Review of the emergence of xylazine and other common adulterant in the United States illicit opioid supply, potential clinical harms and public health implications of combined xylazine and opioid exposures...

Review of evidence and opportunities for interdisciplinary care teams regarding culturally responsive interventions for substance use disorders, clinical practice recommendations for a culturally informed, whole-person approach to Medications for Opioid Use Disorder care...

This webinar will serve as an introduction to the application of traditional, complementary and integrative medicine in clinical care for people experiencing substance use disorders...

Review of sequenced medication strategies to treat ADHD, anxiety disorders, depression, PTSD and sleep disorders; considerations for patients with substance use disorders; and when to refer to a psychiatrist.

Overview of historical and societal context of pain & substance use; interrelationships between pain & substance use; principles of pain treatment in opioid & other substance use disorders; and practical considerations in acute, chronic and terminal pain in patient on MOUD.

Review of relationship between Substance Use Disorder (SUD) and ADHD; treatment strategies for SUD in ADHD; and characteristics and methods to reduce prescription stimulant misuse.

Review of assessing severity of alcohol use disorder (AUD); assessment of withdrawal and outpatient detoxification; medications for treating AUD; integrating medication and behavioral treatments; treating AUD in patients receiving medications for opioid use disorder...